Printer Friendly
The Free Library
14,507,668 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Webcast Alert: Biovail Corporation Presentation at Informed Investors International Pharmaceuticals Virtual Forum to be Webcast on Tuesday, November 9, 2004, 3:30 pm ET.


NEW YORK New York, state, United States
New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of
 -- Biovail Corp. (NYSE NYSE

See: New York Stock Exchange
: BVF BVF Biovail Corporation (stock symbol)
BVF Berufsverband der Frauenärzte eV (Muenchen, Germany)
BVF Bearing Versus Frequency
) will webcast the following presentation:
Sponsor: New York Stock Exchange

What:    Biovail Corp. (NYSE: BVF) will give a presentation at
         Informed Investors International Pharmaceuticals Virtual
         Forum.

         Catherine R. Kinney, President and Co-Chief Operating Officer
         of the New York Stock Exchange, will deliver the keynote
         address at 2 pm EST.

When:    November 9, 2004 @ 3:30 PM Eastern Time

Where:   http://www.vcall.com/CustomEvent/NA014562/IIF.asp?ID=89234

How:     Live over the Internet -- Simply log on to the web at the
         address above.

Contact: Kenneth Howling, 416-285-6499, khowling@biovail.com


If you are unable to participate during the live webcast, the call will be available for replay at http://www.vcall.com/CustomEvent/NA014562/IIF.asp?ID=89234.

Biovail Corporation is a pharmaceutical company engaged in the development, manufacture, marketing, licensing and distribution of pharmaceutical products for the treatment of chronic medical conditions primarily in North America. The Company's primary focus is on therapeutic areas, such as cardiovascular disease, central nervous system (CNS See Continuous net settlement.

CNS

See continuous net settlement (CNS).
) disorders and pain management. Other areas of interest include Type II diabetes Type II diabetes
Type II diabetes is the most common form of diabetes and usually appears in middle aged adults. It is often associated with obesity and may be delayed or controlled with diet and exercise.

Mentioned in: Diabetic Ketoacidosis
, antiviral medicine and select niche therapeutic categories with identified potential. Its commercial portfolio of cardiovascular therapeutic products in the United States includes Cardizem LA, Cardizem CD, Tiazac, Vasotec, Vaseretic, Teveten, Teveten HCT Hct
abbr.
hematocrit


HCT Hematocrit, see there
, Isordil and a number of generic pharmaceutical products. During the year ended December 31, 2003, the Company's operations were organized into five categories: Promoted Products, Biovail Pharmaceuticals Canada (BPC BPC British Potato Council
BPC Brewton-Parker College (Mt Vernon, GA)
BPC Bible Presbyterian Church
BPC Bangladesh Petroleum Corporation (Chittagong, Bangladesh)
BPC British Pharmaceutical Codex
), Wellbutrin XL, Legacy Products and Generic Products.

FORUM CONTACT: Cary Loeser, Informed Investors, 804-327-3407, cloeser@wilink.com

Web site: http://www.informedinvestors.com
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1CANA
Date:Nov 9, 2004
Words:266
Previous Article:Community Partnership of Southern Arizona Deploys GlobalCerts SecureMail Gateway for Email Encryption and HIPAA Compliance.
Next Article:Infrasource Services, Inc. to Release 2004 Third Quarter Results and Hold Conference Call on November 15, 2004.
Topics:



Related Articles
Biovail Announces Third Quarter 2004 Earnings Release, Conference-Call Details.
Upcoming AICPA Webcasts.(Advertisement)
Regeneron to Webcast Presentations at Two Investor Conferences.
Webcast Alert: GlaxoSmithKline plc Presentation at Informed Investors International Pharmaceuticals Virtual Forum to be Webcast on Tuesday, November...
Webcast Alert: Novartis AG Presentation at Informed Investors International Pharmaceuticals Virtual Forum to be Webcast on Tuesday, November 9, 2004,...
Upcoming AICPA webcasts.(New Resources)
First Horizon to Present on May 3, 2005 at the Deutsche Bank Securities Inc. Health Care Conference.
Biovail to Present at the UBS 2005 Global Pharmaceuticals Conference.
Biovail Announces Results of 2004 Annual and Special Meeting of Shareholders.
Biovail to Present at the JPMorgan Annual High Yield Conference 2007.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles